The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
| ||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 4D MOLECULAR THERAPEUTICS IN | COM | 35104E100 | 16,215,000 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
| ABCELLERA BIOLOGICS INC | COM | 00288U106 | 2,929,979 | 1,126,915 | SH | SOLE | 1,126,915 | 0 | 0 | ||
| ALIBABA GROUP HLDG LTD | SPONSORED ADS | 01609W102 | 53,147,761 | 500,827 | SH | SOLE | 500,827 | 0 | 0 | ||
| ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 32,558,876 | 118,383 | SH | SOLE | 118,383 | 0 | 0 | ||
| AMICUS THERAPEUTICS INC | COM | 03152W109 | 26,700,000 | 2,500,000 | SH | SOLE | 2,500,000 | 0 | 0 | ||
| ARRIVENT BIOPHARMA INC | COM | 04272N102 | 35,374,903 | 1,505,315 | SH | SOLE | 1,505,315 | 0 | 0 | ||
| ASML HOLDING N V | N Y REGISTRY SHS | N07059210 | 111,102,222 | 133,336 | SH | SOLE | 133,336 | 0 | 0 | ||
| BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 34,442,100 | 490,000 | SH | SOLE | 490,000 | 0 | 0 | ||
| BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 16,187,500 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
| BROOKFIELD ASSET MANAGMT LTD | CL A LMT VTG SHS | 113004105 | 29,660,619 | 627,207 | SH | SOLE | 627,207 | 0 | 0 | ||
| BROOKFIELD CORP | CL A LTD VT SH | 11271J107 | 185,558,875 | 3,491,230 | SH | SOLE | 3,491,230 | 0 | 0 | ||
| CABLE ONE INC | COM | 12685J105 | 41,416,185 | 118,403 | SH | SOLE | 118,403 | 0 | 0 | ||
| CARGO THERAPEUTICS INC | COM | 14179K101 | 28,486,800 | 1,544,000 | SH | SOLE | 1,544,000 | 0 | 0 | ||
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 32,754,905 | 963,663 | SH | SOLE | 963,663 | 0 | 0 | ||
| CORCEPT THERAPEUTICS INC | COM | 218352102 | 111,597,833 | 2,411,362 | SH | SOLE | 2,411,362 | 0 | 0 | ||
| CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 51,100,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 148,126,831 | 5,549,900 | SH | SOLE | 5,549,900 | 0 | 0 | ||
| GALECTO INC | COM NEW | 36322Q206 | 1,213,943 | 99,913 | SH | SOLE | 99,913 | 0 | 0 | ||
| INSMED INC | COM PAR $.01 | 457669307 | 52,900,618 | 724,666 | SH | SOLE | 724,666 | 0 | 0 | ||
| IO BIOTECH INC | COM | 449778109 | 3,522,171 | 3,354,449 | SH | SOLE | 3,354,449 | 0 | 0 | ||
| KYVERNA THERAPEUTICS INC | COM | 501976104 | 9,046,500 | 1,850,000 | SH | SOLE | 1,850,000 | 0 | 0 | ||
| LANZATECH GLOBAL INC | COM | 51655R101 | 30,206,354 | 15,814,845 | SH | SOLE | 15,814,845 | 0 | 0 | ||
| LEXEO THERAPEUTICS INC | COM | 52886X107 | 10,148,132 | 1,122,581 | SH | SOLE | 1,122,581 | 0 | 0 | ||
| MARQETA INC | CLASS A COM | 57142B104 | 2,172,465 | 441,558 | SH | SOLE | 441,558 | 0 | 0 | ||
| MERUS N V | COM | N5749R100 | 34,972,000 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
| METAGENOMI INC | COM | 59102M104 | 3,906,000 | 1,800,000 | SH | SOLE | 1,800,000 | 0 | 0 | ||
| MIRUM PHARMACEUTICALS INC | COM | 604749101 | 58,500,000 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
| PHARVARIS N V | COM | N69605108 | 31,947,000 | 1,725,000 | SH | SOLE | 1,725,000 | 0 | 0 | ||
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 20,317,000 | 1,100,000 | SH | SOLE | 1,100,000 | 0 | 0 | ||
| SALESFORCE INC | COM | 79466L302 | 100,878,558 | 368,560 | SH | SOLE | 368,560 | 0 | 0 | ||
| SPERO THERAPEUTICS INC | COM | 84833T103 | 628,329 | 468,902 | SH | SOLE | 468,902 | 0 | 0 | ||
| TEMPUS AI INC | CL A | 88023B103 | 230,612,115 | 4,074,419 | SH | SOLE | 4,074,419 | 0 | 0 | ||
| VANGUARD INDEX FDS | TOTAL STK MKT | 922908769 | 294,075,818 | 1,038,550 | SH | SOLE | 1,038,550 | 0 | 0 | ||
| VAXCYTE INC | COM | 92243G108 | 85,702,500 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
| VERVE THERAPEUTICS INC | COM | 92539P101 | 11,616,000 | 2,400,000 | SH | SOLE | 2,400,000 | 0 | 0 | ||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 54,258,750 | 2,385,000 | SH | SOLE | 2,385,000 | 0 | 0 | ||
| ZENAS BIOPHARMA INC | COM | 98937L105 | 19,458,000 | 1,150,000 | SH | SOLE | 1,150,000 | 0 | 0 | ||
